Targeting Neuroinflammation to Treat ALS
RARECast - Un pódcast de RARECast - Jueves
Categorías:
Howard Berman, chairman and CEO of Coya Therapeutics, discusses the role of inflammation in neurodegenerative conditions, regulatory T cells, and the company’s experimental therapy to treat ALS.
